NEU 0.85% $15.14 neuren pharmaceuticals limited

62c npv; $2b potential sales; us army backing, page-18

  1. 16,461 Posts.
    lightbulb Created with Sketch. 774
    62c npv and stock price stalls at 2c, cash levels and grants are worth double that alone not to mention a potential pre clinical deal with a major pharma for their cancer therapies may be a short term possibility .
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.